Drug profile · INN
triheptanoin
DOJOLVI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
triheptanoin (DOJOLVI) is an FDA-listed pharmaceutical active ingredient. Associated with Ultragenyx UK Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is triheptanoin?
triheptanoin (DOJOLVI) is an FDA-listed pharmaceutical active ingredient. Associated with Ultragenyx UK Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for triheptanoin?
DOJOLVI is a marketed brand name for triheptanoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triheptanoin?
triheptanoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.